[Clinical and hemodynamic efficiency of dilatrend treatment in patients with dilatation cardiomyopathy].
In present study we describe the clinical case of successful treatment of dilatation cardiomyophaty based on dilatrend using. 32 years old patient with acute heart failure and rhythm dysfunction was active user of alcohol since 1993. At the beginning of treatment 25 mg of dilatrend twice per day was used. The dose was increased monthly by 2.5 mg. After 4 months of treatment clinical signs of disease were eliminated at the daily dose 50 mg of dilatrend. In order to recover from arrhythmia on the seventh month of treatment cardioversion was successfully carried out. As it follows from our experience dilatrend is very effective for treatment of dilatative cardiomyopathy of alcoholic genesis.
Dzhaniashvili
M I
MI
Chanturiia
N G
NG
Panchulidze
G A
GA
D000328:Adult; D002227:Carbazoles / Q000627:therapeutic use*; D002311:Cardiomyopathy, Dilated / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology*; D000077261:Carvedilol; D004562:Electrocardiography; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D008297:Male; D011412:Propanolamines / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D002227:Carbazoles; D011412:Propanolamines; D014665:Vasodilator Agents; D000077261:Carvedilol